|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
ATE355854T1
(de)
*
|
2000-08-03 |
2007-03-15 |
Antares Pharma Ipl Ag |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
|
US6566556B2
(en)
*
|
2000-12-19 |
2003-05-20 |
Nippon Shokubai Co., Ltd. |
Method for production of alkanolamine and apparatus therefor
|
|
JP2004522803A
(ja)
*
|
2001-06-29 |
2004-07-29 |
マキシゲン・エイピーエス |
インターフェロン製剤
|
|
US7141540B2
(en)
*
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
|
ES2745068T3
(es)
*
|
2001-12-20 |
2020-02-27 |
Merck Sharp & Dohme |
Composiciones de SYN3 y métodos
|
|
BR0307898A
(pt)
*
|
2002-02-22 |
2004-12-07 |
Pharmacia Corp |
Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
|
|
EP1476135A1
(en)
*
|
2002-02-22 |
2004-11-17 |
Pharmacia Corporation |
Ophthalmic formulation with gum system
|
|
DK1670433T3
(da)
|
2003-10-10 |
2012-03-12 |
Ferring Bv |
Transdermal farmaceutisk formulering til mindskelse af hudrester
|
|
WO2005105827A2
(en)
|
2004-04-15 |
2005-11-10 |
Proteolix, Inc. |
Compounds for proteasome enzyme inhibition
|
|
US8198270B2
(en)
*
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
US8088741B2
(en)
*
|
2004-05-10 |
2012-01-03 |
Onyx Therapeutics, Inc. |
Compounds for enzyme inhibition
|
|
HUE027850T2
(en)
*
|
2004-12-07 |
2016-11-28 |
Onyx Therapeutics Inc |
Preparation for proteasome inhibition
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
RU2453556C2
(ru)
|
2005-11-09 |
2012-06-20 |
Протеоликс, Инк. |
Соединения для ингибирования фермента
|
|
WO2007059507A2
(en)
*
|
2005-11-15 |
2007-05-24 |
Baxter International, Inc. |
Compositions comprising lipoxygenase inhibitors and cyclodextrin
|
|
US20070135586A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Shreyas Chakravarti |
Polyamide blend compositions formed article and process thereof
|
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
RU2450016C2
(ru)
|
2006-06-19 |
2012-05-10 |
Протеоликс, Инк. |
Пептидные эпоксикетоны для ингибирования протеасомы
|
|
EP2061458B1
(en)
*
|
2006-09-15 |
2014-12-10 |
Regents of the University of Minnesota |
Topiramate compositions and methods for their use
|
|
US20090239942A1
(en)
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
CN101686681B
(zh)
|
2007-04-27 |
2015-04-01 |
锡德克斯药物公司 |
包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
|
|
WO2009018326A2
(en)
*
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Soluble pyrone analogs methods and compositions
|
|
KR20170040374A
(ko)
|
2007-10-04 |
2017-04-12 |
오닉스 세라퓨틱스, 인크. |
결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성
|
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
|
CA2762321A1
(en)
*
|
2008-05-19 |
2009-11-26 |
Texcontor Etablissement |
Fosphenytoin composition
|
|
AU2009308516B2
(en)
|
2008-10-21 |
2016-08-25 |
Onyx Therapeutics, Inc. |
Combination therapy with peptide epoxyketones
|
|
US10463677B2
(en)
|
2008-11-07 |
2019-11-05 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
|
AR075899A1
(es)
|
2009-03-20 |
2011-05-04 |
Onyx Therapeutics Inc |
Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
|
|
WO2010132711A1
(en)
|
2009-05-13 |
2010-11-18 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
|
CA2763365C
(en)
|
2009-05-29 |
2016-09-13 |
Cydex Pharmaceuticals, Inc. |
Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
|
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
|
LT2445502T
(lt)
|
2009-06-25 |
2017-09-25 |
Alkermes Pharma Ireland Limited |
Heterocikliniai junginiai, skirti neurologinių ir fiziologinių susirgimų gydymui
|
|
CA2937222C
(en)
|
2009-06-25 |
2019-06-04 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds
|
|
JP5919196B2
(ja)
|
2009-11-13 |
2016-05-18 |
オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
転移抑制のためのペプチドエポキシケトンの使用
|
|
CA2791651C
(en)
|
2010-03-01 |
2019-08-20 |
Onyx Therapeutics, Inc. |
Compounds for immunoproteasome inhibition
|
|
NZ602872A
(en)
|
2010-04-07 |
2014-05-30 |
Onyx Therapeutics Inc |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
|
AU2011270701B2
(en)
|
2010-06-24 |
2015-05-14 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
DE102011011028A1
(de)
*
|
2011-02-11 |
2012-08-16 |
Ditter Plastic Gmbh + Co. Kg |
Frontplatte mit darin eingespritztem Lichtleiter
|
|
BR112013023847B1
(pt)
|
2011-03-18 |
2021-02-23 |
Alkermes Pharma Ireland Limited |
composições farmacêuticas compreendendo ésteres de sorbitano e uso das mesmas
|
|
WO2013040286A2
(en)
|
2011-09-18 |
2013-03-21 |
Euro-Celtique S.A. |
Pharmaceutical compositions
|
|
NZ722096A
(en)
|
2011-12-15 |
2016-11-25 |
Alkermes Pharma Ireland Ltd |
Prodrugs of secondary amine compounds
|
|
AR092790A1
(es)
|
2012-02-01 |
2015-05-06 |
Euro Celtique Sa |
Derivados bencimidazolicos del acido hidroxamico
|
|
DK3702374T3
(da)
|
2012-02-15 |
2022-06-27 |
Cydex Pharmaceuticals Inc |
Fremsgangsmåde til fremstilling for cyclodextrin-derivater
|
|
HK1211311A1
(en)
|
2012-02-28 |
2016-05-20 |
锡德克斯药物公司 |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
|
CA2867121C
(en)
|
2012-03-19 |
2021-05-25 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising fatty acid esters
|
|
AU2013235523B9
(en)
|
2012-03-19 |
2018-01-04 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising glycerol esters
|
|
AU2013235526B2
(en)
|
2012-03-19 |
2017-11-30 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
|
JP2015524394A
(ja)
|
2012-07-09 |
2015-08-24 |
オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
ペプチドエポキシケトンプロテアーゼ阻害剤のプロドラッグ
|
|
JP6654042B2
(ja)
|
2012-09-19 |
2020-02-26 |
アルカームス ファーマ アイルランド リミテッド |
貯蔵安定性が改善された医薬組成物
|
|
WO2014066274A1
(en)
|
2012-10-22 |
2014-05-01 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
|
CN106132415A
(zh)
|
2014-03-20 |
2016-11-16 |
奥克梅斯制药爱尔兰有限公司 |
具有增加的注射速度的阿立哌唑制剂
|
|
GB201409485D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
JP6914188B2
(ja)
|
2014-08-22 |
2021-08-04 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
分画アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法
|
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
|
AU2016426574B2
(en)
|
2016-10-11 |
2023-07-13 |
Euro-Celtique S.A. |
Hodgkin lymphoma therapy
|
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
|
EP3761983A1
(en)
|
2018-03-05 |
2021-01-13 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
CN113365624A
(zh)
|
2018-12-18 |
2021-09-07 |
萌蒂制药国际有限公司 |
用于治疗淋巴瘤或t-细胞恶性疾病的化合物
|
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
|
CN110279664B
(zh)
*
|
2019-07-30 |
2021-09-03 |
四川农业大学 |
一种氟苯尼考包合物冻干粉针剂及其制备方法
|
|
CA3149914A1
(en)
|
2019-08-06 |
2021-02-11 |
L.E.A.F. Holdings Group Llc |
Processes of preparing polyglutamated antifolates and uses of their compositions
|
|
JP2023551145A
(ja)
|
2020-11-18 |
2023-12-07 |
ベクソン バイオメディカル，インク． |
医薬化合物の錯化剤塩製剤
|
|
WO2022116134A1
(zh)
|
2020-12-04 |
2022-06-09 |
四川科瑞德制药股份有限公司 |
磷苯妥英钠固体组合物、冻干方法、及其用途
|
|
CN114588116B
(zh)
*
|
2020-12-04 |
2024-03-15 |
四川科瑞德制药股份有限公司 |
磷苯妥英钠固体组合物、冻干方法、及其用途
|
|
US20250345458A1
(en)
*
|
2022-05-18 |
2025-11-13 |
Bexson Biomedical, Inc. |
Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios
|
|
WO2024231293A1
(en)
|
2023-05-05 |
2024-11-14 |
Euro-Celtique S.A. |
Combinations for treating cancer
|